| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| X4011 |
State-specific procedure code |
525 |
479 |
$198K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
999 |
916 |
$172K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
690 |
642 |
$160K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
982 |
954 |
$151K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,921 |
4,615 |
$129K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
705 |
657 |
$62K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
522 |
519 |
$50K |
| 80053 |
Comprehensive metabolic panel |
3,750 |
3,578 |
$49K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
428 |
218 |
$29K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
901 |
843 |
$27K |
| X4006 |
|
36 |
30 |
$21K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
521 |
518 |
$19K |
| 71046 |
Radiologic examination, chest; 2 views |
280 |
258 |
$17K |
| Y7506 |
|
157 |
146 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
601 |
528 |
$14K |
| 81001 |
|
416 |
398 |
$14K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
38 |
38 |
$14K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
356 |
350 |
$13K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
338 |
333 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
92 |
71 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
57 |
55 |
$12K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
76 |
65 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
546 |
540 |
$7K |
| 80061 |
Lipid panel |
651 |
642 |
$7K |
| 87660 |
|
192 |
183 |
$7K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
332 |
331 |
$7K |
| 87480 |
|
160 |
153 |
$6K |
| 84484 |
|
432 |
367 |
$6K |
| 87510 |
|
75 |
73 |
$5K |
| 87081 |
|
583 |
573 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
87 |
86 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
156 |
150 |
$4K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
18 |
17 |
$4K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
103 |
101 |
$4K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
57 |
51 |
$4K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
64 |
62 |
$3K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
105 |
102 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
16 |
14 |
$2K |
| 80081 |
|
13 |
13 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
94 |
86 |
$2K |
| 81025 |
|
186 |
184 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
112 |
112 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
145 |
143 |
$2K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
46 |
46 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
65 |
64 |
$700.00 |
| 86850 |
|
13 |
13 |
$500.02 |
| 84439 |
|
67 |
66 |
$487.85 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
28 |
28 |
$427.09 |
| 86696 |
|
28 |
28 |
$378.74 |
| 83690 |
|
109 |
105 |
$365.30 |
| 86592 |
|
129 |
129 |
$338.78 |
| 86695 |
|
28 |
28 |
$258.03 |
| 87340 |
|
29 |
29 |
$207.71 |
| 86140 |
|
49 |
49 |
$180.77 |
| 81003 |
|
86 |
81 |
$99.64 |
| 85652 |
|
49 |
49 |
$94.20 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
35 |
34 |
$47.81 |
| 85027 |
|
13 |
12 |
$47.74 |
| 84550 |
|
16 |
15 |
$35.64 |
| J3490 |
Unclassified drugs |
124 |
100 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
15 |
15 |
$0.00 |